Biopharma News

Dec 01, 2014
BioPharm International
By BioPharm International Editors
Medtronic announced that it received clearance from both the FTC and European Commission to acquire Covidien for $43 billion.
Dec 01, 2014
BioPharm International
By BioPharm International Editors
Dalton Pharma Services announced it was awarded funding from ISTPCanada for its project to develop vaccines for respiratory syncytial virus and parainfluenza type 3.
Dec 01, 2014
BioPharm International
Biotech drug manufacturers' emails may have been hacked by individuals with sophisticated investment banking skills, according to a report from the New York Times.
Nov 26, 2014
Opdivo and investigational agent FPA008 will be tested in combination for their efficacy in boosting antitumor immune response.
Nov 25, 2014
By BioPharm International Editors
The more than $200 million project will increase production capacity at the facility to support AstraZeneca?s maturing pipeline.
Nov 25, 2014
By BioPharm International Editors
Merck announced an agreement with NewLink Genetics to acquire exclusive rights to its experimental Ebola vaccine, rVSV-EBOV, for $50 million.
Nov 24, 2014
An index from the Access to Medicine Foundation ranks GSK as most effective in making products accessible.
Nov 24, 2014
By BioPharm International Editors
Ulf Wiinberg has resigned as Lundbeck's CEO over unapproved acceptance of shares in a biotech company.
Nov 24, 2014
By BioPharm International Editors
GSK and Novartis announced a meeting on Dec. 18, 2014 to discuss the $20 billion asset swap between the two companies.
Nov 24, 2014
The announcement calls attention to another partnership in the growing T-cell receptor engineering space.
native1_300x100
lorem ipsum